(Q54232270)

26 May 2018

title

Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora. (English)

1 reference

26 May 2018

1 reference

B Brismar

1

1 reference

26 May 2018

C Edlund

series ordinal

2

1 reference

26 May 2018

C E Nord

series ordinal

3

1 reference

26 May 2018

publication date

1 September 1993

1 reference

26 May 2018

European Journal of Clinical Microbiology & Infectious Diseases

published in

1 reference

26 May 2018

volume

12

1 reference

26 May 2018

issue

9

1 reference

26 May 2018

page(s)

714-719

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1007/bf02009388

exact match

0 references

cites work

Impact of antimicrobial agents on human intestinal microflora

1 reference

https://api.crossref.org/works/10.1007%2FBF02009388

In vitro activity of U-76,252 (CS-807), a new oral cephalosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02009388

Effect of Phenoxymethylpenicillin and Clindamycin on the Oral, Throat and Faecal Microflora of Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02009388

Presence of Clostridium difficile and antibiotic and beta-lactamase activities in feces of volunteers treated with oral cefixime, oral cefpodoxime proxetil, or placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02009388

Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment

21 January 2018

1 reference

12 December 2020

A Review of the Pharmacokinetics of Cefpodoxime Proxetil

1 reference

12 December 2020

Microbiological Evaluation of Cefpodoxime Proxetil

1 reference

12 December 2020

Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02009388

1 reference

26 May 2018

1 reference

26 May 2018